Your browser doesn't support javascript.
loading
Drug prices and trends before and after requesting compulsory licenses: the Ecuadorian experience.
Ortiz-Prado, Esteban; Cevallos-Sierra, Gabriel; Teran, Enrique; Vasconez, Eduardo; Borrero-Maldonado, Daniel; Ponce Zea, Jorge; Simbaña-Rivera, Katherine; Gómez-Barreno, Lenin.
Afiliação
  • Ortiz-Prado E; a OneHealth Research Group, Faculty of Medicine, Universidad De Las Americas , Quito , Ecuador.
  • Cevallos-Sierra G; a OneHealth Research Group, Faculty of Medicine, Universidad De Las Americas , Quito , Ecuador.
  • Teran E; b Colegio de Ciencias de la Salud, Universidad San Francisco de Quito , Quito , Ecuador.
  • Vasconez E; a OneHealth Research Group, Faculty of Medicine, Universidad De Las Americas , Quito , Ecuador.
  • Borrero-Maldonado D; a OneHealth Research Group, Faculty of Medicine, Universidad De Las Americas , Quito , Ecuador.
  • Ponce Zea J; c Department of Clinical Laboratory, Faculty of Medical Science, Universidad Estatal del Sur de Manabí , Jipijapa , Ecuador.
  • Simbaña-Rivera K; a OneHealth Research Group, Faculty of Medicine, Universidad De Las Americas , Quito , Ecuador.
  • Gómez-Barreno L; a OneHealth Research Group, Faculty of Medicine, Universidad De Las Americas , Quito , Ecuador.
Expert Opin Ther Pat ; 29(8): 653-662, 2019 Aug.
Article em En | MEDLINE | ID: mdl-31298053
Introduction: The Ecuadorian Institute of Intellectual Property (IEPI) granted several compulsory licenses between 2011 and 2017. In 2009, the President of Ecuador signed a decree that was intended to facilitate the request of compulsory licenses (CL) in the country, not only for Enfarma EP but for any privately owned local company in order to produce more accessible medicines. Areas covered: The national and international regulatory framework of pharmaceutical patents and the local applicability of CL in Ecuador. The authors also analyzed the results of requesting unplanned and epidemiologically unnecessary CL at a national level. Finally, the authors reviewed the effects of requesting, granting or denying CL on price per unit in the last 7 years of available data. Expert opinion: The authors think that compulsory licenses are useful tools when negotiating drug prices or when the demand cannot be satisfied due to economic constrain within the local health system. However, the authors' experience suggests that Ecuador did not have an established and reliable production system neither an adequate plan before requesting CL, therefore the positive effects of this measure were not clearly established.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Custos de Medicamentos / Indústria Farmacêutica / Licenciamento Tipo de estudo: Health_economic_evaluation Limite: Humans País/Região como assunto: America do sul / Ecuador Idioma: En Revista: Expert Opin Ther Pat Assunto da revista: TERAPEUTICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Equador País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Custos de Medicamentos / Indústria Farmacêutica / Licenciamento Tipo de estudo: Health_economic_evaluation Limite: Humans País/Região como assunto: America do sul / Ecuador Idioma: En Revista: Expert Opin Ther Pat Assunto da revista: TERAPEUTICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Equador País de publicação: Reino Unido